Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial

Study limitation reported by the research below: “The trial enrolled participants aged 7–25, spanning pediatric through young adult age groups — results may not apply uniformly across this wide age range.”